
Ziphius appoints vaccine veteran Antoon Loomans to board to boost strategic growth and funding.
Ziphius, a biotech firm specializing in self-amplifying RNA vaccines, has appointed Antoon Loomans to its board of directors to lead U.S. business development and strategic partnerships. Loomans brings 30 years of vaccine industry experience, includi...





